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Psoriasis is a common inflammatory skin disorder clinically characterized by sharply demarcated chronic erythematous plaques, covered by silvery white scales, preferentially at the elbow, knee, scalp, umbilicus and lumbar area.' Examination of available population based studies reveal prevalence ranging from 0.2% to 4.8%. 2 Patients with psoriasis appear to have an increased morbidity and mortality from cardiovascular events, especially those with a severe and long duration of psoriasis. However, the pathogenesis of atherothrombotic events in psoriasis patients remains to be established. Multiple factors including aberrant lipid and lipoprotein profiles, increased oxidative stress, decreased antioxidant capacity and other established risk factors such as hypertension, obesity and diabetes mellitus have been associated with psoriasis. 3 Alcoholism and smoking are the important risk factors for coronary heart disease. It has been shown that smoking and alcoholism are also important risk factor for psoriasis. 4 Dyslipidemia is another important cardiovascular risk factor. Studies have suggested the hypothesis that psoriasis may be a predisposing factor to occlusive vascular episode.
5
We conducted this study to show that like other risk factors common to heart disease and psoriasis, serum lipid abnormality may be associated with psoriasis risk.
MATERIALS AND METHODS
The study was designed as a case control study. The total number of patients were one hundred and six, among them 53 were case and 53 were control. The study subjects were taken from the dermatology OPD of Bir Hospital, Mahabauddha, Kathmandu and Shree Birendra Hospital, chhauni, Kathmandu. The age and sex were matched.
The approval of the study was obtained from the subject committee and Institutional review board, National Academy of Medical Sciences (NAMS), Bir Hospital. The period of this study was one year from January 2010 to December 2010. Any patients presenting with Chronic Plaque type, Pustular and Guttate psoriasis were included as case. Patients with other skin disease were taken as control. The exclusion criteria were: those with the family history of hypertension and hyperlipidemia; patients on medications like beta blockers, oral corticosteroid, lipid lowering agents, thiazide, oral retinoids, patients with known history of diabetes, hypothyroidism, nephrotic syndrome, obstructive liver disease and connective tissue disease, patients below 16 years and above 60 years.
A written informed consent was taken after explaining all the relevant details and its importance. Those who did not give consent for any reasons were excluded from the study. Confidentiality was maintained.
The venous blood samples were taken from the patient after overnight fast. After collecting blood, it was allowed to clot and serum was used for detection ofSerumTriglyceride (TG), Total cholesterol (TC), High density lipoprotein (HDL) and Low density Lipoprotein (LDL).The determination ofTG, TC and HDL was done through the auto-analyser (ERBA diagnostic Mannheim GmbH, Germany) through enzymatic colorimetric assay. LDL was calculated manually in lab from the formula: LDL-C= TC-(TG/5 + HDL ).
All the patients were diagnosed clinically and the severity of psoriasis was assessed by PASI score. 6 Demographic and other data were recorded in performa through questionnaire and lab report. BMI was calculated by the formula: BMI =weight in Kg I square ofheight in meters.
Microsoft excel and SPSS statistics Ver.17 were used for recording and analyzing data. Descriptive statistics methods like central tendency calculation, deviation/dispersion calculation were worked out. Fisher's exact test, Chi-square test, independent t test, correlation analysis were used. Level of significance (0.05) was predetermined and CI (confidence interval) of95% was constructed.
RESULTS
The total number was 106, among them 49 .1 % were male and 50.9% were female. Three types of psoriasis were included in this study (table 1 ) . The maximum number was Chronic Plaque type. Most of the patients have a chronic course of more than 2 years duration reflecting the fact that psoriasis is a chronic disease. Those diseases taken as control were melasma, acne, superficial skin infection, urticaria. Smoking and alcoholism are two important risk factors associated with psoriasis. Significant association was found between smoking and psoriasis ( Table 2 ). In the clinical and demographic characteristics of patients like age, height, weight, BMI and BP, no significant difference were found. PASirangedfrom2 to29.38. (Table 3) To find the relation between PASI score and associated abnormalities in lipid parameters, the data was analysed and recorded and no significant association between severity of psoriasis and lipid abnormality was noted. Similarly correlation analysis was done and it showed weak correlation betweenPASI score andHDL(r=l 79).
Lipid abnormality was also seen in smoker and alcoholics. Considering smoking and alcoholism as confounding variables, without adjusting for these factors odd ratio for TG and TC were 4.086 and 2.566 indicating abnormal TG and TC and is approximately 4 and 2.5 times likely to be associated with psoriasis. Since there were no abnormal lipid values for HDL and LDL in control the odd ratio was not calculated.
DISCUSSION
The study showed that abnormal lipid profile is associated with psoriasis. Among four lipid parameters that were considered in study only three parameters TG, TC and HDL are associated without adjusting for the risk factors.
The result is consistent with the studies done in the past. The study of Piskin 7 showed association ofLDL and TC. Dratlen's study 8 showed only abnormal HDL is associated with psoriasis. The study by Akhyami 9 showed abnormal TC, TG and LDL but not HDL to be associated with psoriasis. In the study done by Malbris 3 only abnormal HDL was associated with psoriasis. The study by Aldhalimi 10 showed association of only LDL,TC and TG with psoriasis. As in our study most studies showed association of abnormal TG with psoriasis. Abnormal LDL though found to be associated in other few studies, was not found in our study. This indicates that our study supports the evidence that abnormal serum lipids is associated with psoriasis.
After adjusting the risk factors like smoking and alcohol, only association of abnormal level of TC and TG was seen with psoriasis. Malbris with psoriasis, but after adjustment only HDL was associated. This shows that confounding variables like smoking and alcoholism need to be considered in psoriatic patients as these factors may lead to hyerlipidemia.
Our study showed no relation between disease severity and abnormal lipid profile, but weak correlation between HDL and severity of psoriasis. Study ofMalbris 3 showed no correlation but Gisondi et al 11 showed significant correlation between severity of psoriasis and triglyceridemia. There are conflicting and limited study between severity of psoriasis and associated dyslipidemia. Further study is needed in this regard.
Elevated serum TG and lowserum HDL have been reported to be risk factors for the occlusive vascular disease. Patients with psoriasis have known microvascular abnormalities in both affected and unaffected skin. The reason for the changes in lipid metabolism in psoriasis patients have not been satisfactorily explained, since psoriasis is influenced by disorder in genetic alteration which may play a role for the dyslipidemia. 8 
CONCLUSION
Abnormal serum lipid profile is seen to be associated with psoriasis, it is important to note that psoriasis may not only be disorder of skin; systemic involvement should also be considered.
